Generate a tailored SOP for Dr. Shengliang Zhang. Improve your application with a focused, well-structured draft.
Shengliang Zhang is an Assistant Professor in the Department of Pathology and Laboratory Medicine at Brown University. His research primarily focuses on drug development aimed at targeting the p53 protein, elucidating new drug mechanisms for cancer therapies. With a solid background in molecular cellular oncology, he obtained his Ph.D. from Tokyo Medical Dental University, Japan. Subsequently, he pursued postdoctoral training in gene expression and cell differentiation at the Perelman School of Medicine at the University of Pennsylvania. In addition to his research activities, Dr. Zhang is actively involved in academic publishing, serving as an Associate Editor for the Cancer Molecular Targets Therapeutics Section of Frontiers in Oncology and as a member of the editorial board for Cancer Biology & Therapy.
Department: Department of Economics